Increased CTLA-4 expression results in a net inhibitory response to the T cell itself, leading to decreased T-cell survival, decreased local cytokine release (namely IL-2 [29]), and a more “pro-tumor” microenvironment. Here, CTLA4 is linked to neoplasm.